Absci (ABSI) Amortizatization of Intangibles (2022 - 2026)
Absci (ABSI) posted Amortizatization of Intangibles of $421000.0 for Q1 2026, down 20.11% sequentially from $527000.0 in Q4 2025, and down 39.77% YoY from $699000.0 in Q1 2025.
Analysis
Absci (ABSI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Absci has reported Amortizatization of Intangibles for 5 years, with the latest figure at $421000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 39.77% year-over-year to $421000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 40.57% YoY) and the FY2025 annual result came in at $2.5 million, down 32.06% from the prior year.
- Amortizatization of Intangibles retreated to $421000.0 in Q1 2026 per ABSI's latest filing, from $527000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.2 million in Q2 2024 and troughed at $396000.0 in Q4 2023.
- A 5-year average of $719000.0 and a median of $678500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 97.47% in 2024, then slumped 44.8% in 2025.
- Over 5 years, Amortizatization of Intangibles stood at $688000.0 in 2022, then plunged by 42.44% to $396000.0 in 2023, then surged by 97.47% to $782000.0 in 2024, then plunged by 32.61% to $527000.0 in 2025, then dropped by 20.11% to $421000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $421000.0, $527000.0, and $648000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | 328,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 328,000.00 |
| Mar 31, 2026 | 421,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Sep 30, 2025 | 648,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Sep 30, 2023 | 629,000.00 |
| Jun 30, 2023 | 814,000.00 |
| Mar 31, 2023 | 832,000.00 |
| Dec 31, 2022 | 688,000.00 |